![Douglas P. Malinowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas P. Malinowski
Technik-/Wissenschafts-/F&E-Leiter bei TriPath Oncology, Inc.
Profil
Douglas P.
Malinowski has been Vice President of Research and Chief Scientific Officer of TriPath Oncology Inc. since November, 2001.
Prior to joining TriPath Oncology, he worked at Becton Dickinson & Co. which he joined in 1983.
He worked at the Becton Dickinson Corporate Research Center (BDRC).
Dr. Malinowski received a BS degree in Chemistry from the University of Notre Dame and a PhD degree in Biochemistry from the Duke University Medical Center.
Aktive Positionen von Douglas P. Malinowski
Unternehmen | Position | Beginn |
---|---|---|
TriPath Oncology, Inc.
![]() TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Douglas P. Malinowski
Unternehmen | Position | Ende |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Douglas P. Malinowski
University of Notre Dame | Undergraduate Degree |
Duke University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
Private Unternehmen | 1 |
---|---|
TriPath Oncology, Inc.
![]() TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |